Vertex Pharmaceuticals (VRTX) Net Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.88% |
| Dec 31, 2025 | -26.29% |
| Sep 30, 2025 | -15.53% |
| Jun 30, 2025 | -27.92% |
| Mar 31, 2025 | -29.88% |
| Dec 31, 2024 | -16.77% |
| Sep 30, 2024 | 42.98% |
| Jun 30, 2024 | -68.10% |
| Mar 31, 2024 | -47.04% |
| Dec 31, 2023 | -45.27% |
| Sep 30, 2023 | 24.20% |
| Jun 30, 2023 | 40.62% |
| Mar 31, 2023 | -41.39% |
| Dec 31, 2022 | 35.83% |
| Sep 30, 2022 | 39.28% |
| Jun 30, 2022 | 36.52% |
| Mar 31, 2022 | 44.87% |
| Dec 31, 2021 | 4.79% |
| Sep 30, 2021 | 13.80% |
| Jun 30, 2021 | -125.84% |
| Mar 31, 2021 | 37.41% |
| Dec 31, 2020 | 76.05% |
| Sep 30, 2020 | 45.76% |
| Jun 30, 2020 | 43.20% |
| Mar 31, 2020 | 63.15% |
| Dec 31, 2019 | -25.88% |
| Sep 30, 2019 | -18.77% |
| Jun 30, 2019 | 145.10% |
| Mar 31, 2019 | 29.71% |
| Dec 31, 2018 | 66.48% |
| Sep 30, 2018 | 46.86% |
| Jun 30, 2018 | 0.30% |
| Mar 31, 2018 | 38.37% |
| Dec 31, 2017 | 39.73% |
| Sep 30, 2017 | 50.40% |
| Jun 30, 2017 | 5.00% |
| Mar 31, 2017 | 2.26% |
| Dec 31, 2016 | 52.29% |
| Sep 30, 2016 | 6.19% |
| Mar 31, 2016 | -20.66% |
| Dec 31, 2015 | 33.99% |
| Sep 30, 2015 | -20.00% |
| Jun 30, 2015 | 40.51% |
| Mar 31, 2015 | 23.24% |
| Dec 31, 2014 | 3.84% |
| Sep 30, 2014 | 14.65% |
| Jun 30, 2014 | 52.45% |
| Mar 31, 2014 | -21.82% |